Soluble interleukin-2 receptors in retinal vasculitis

Area of Science:

• Ophthalmology
• Immunology
• Rheumatology

Background:

• Retinal vasculitis involves inflammation of blood vessels in the retina.
• Soluble interleukin-2 receptor (sIL-2R) is a marker of immune system activation.
• Understanding sIL-2R in retinal vasculitis can offer insights into disease mechanisms.

Purpose of the Study:

• To investigate serum sIL-2R levels in patients with retinal vasculitis.
• To differentiate between ocular-isolated vasculitis and vasculitis with systemic disease.
• To explore the potential role of sIL-2R in specific conditions like sarcoidosis and Fuchs' heterochromic cyclitis.

Main Methods:

• Serum sIL-2R levels were measured in 27 patients with retinal vasculitis (16 RV, 11 RV+SID) and compared to healthy controls.
• Patients were categorized based on whether vasculitis was isolated to the eye or associated with systemic inflammatory disease.
• sIL-2R levels were also assessed in 21 patients with Fuchs' heterochromic cyclitis.

Main Results:

• Significantly elevated sIL-2R levels were observed in the retinal vasculitis with systemic inflammatory disease (RV+SID) group compared to controls (p=0.013).
• The highest sIL-2R levels were found in patients with sarcoidosis.
• Elevated sIL-2R levels were also noted in patients with Fuchs' heterochromic cyclitis (p<0.0001).
• No correlation was found between sIL-2R levels and disease activity or corticosteroid treatment.

Conclusions:

• Serum sIL-2R may serve as a biomarker for retinal vasculitis associated with systemic inflammation, especially in sarcoidosis.
• sIL-2R measurement has limited utility in managing purely ocular retinal vasculitis.
• The elevated sIL-2R in Fuchs' heterochromic cyclitis warrants further investigation due to the condition's chronic and typically mild inflammatory nature.